Clinical Trial Update: Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating Celiprolol versus placebo for vascular Ehlers-Danlos syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Ehlers-danlos Syndrome

Drugs mentioned

• Celiprolol (celiprolol)

Snippet

Sponsor: Acer Therapeutics Inc. | Conditions: Vascular Ehlers-Danlos Syndrome | Phase 3 | Status: RECRUITING